T-cell intravascular lymphomatosis (angiotropic large cell lymphoma): Association with Epstein-Barr viral infection

Histopathology

Volumn 31, Issue 6, 1997, Pages 563-567

  Au, W Y ^a   Shek, W H ^a   Nicholls, J ^a   Tse, K M ^a   Todd, D ^a   Kwong, Y L ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Epstein Barr virus; Intravascular lymphomatosis; T cell

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA; LYMPHOMATOSIS; MALE; NASOPHARYNX CANCER; PRIORITY JOURNAL; VIRUS INFECTION;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0031442275     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1997.3050903.x     Document Type: Article

References (34)

1. Pfleger L, Tappeiner J. Zur Kenntnis der Systemisierten Endotheliomatose der cuanen Blutegefasse (Reticulo-endotheliose ?). Hautarzt 1959: 10; 359-363.
2. Bhawan J, Wolff SM, Ucci AA, Bhan AK. Malignant lymphoma and malignant angioendotheliomatosis, one disease. Cancer 1985: 55; 570-576.
3. Mori S, Itoyama S, Mohri N et al. Cellular characteristics of neoplastic angioendotheliosis: An immunohistological marker study of 6 cases. Virch. Arch. A Pathol. Anat. Histopathol. 1985: 407; 167-175.
4. Benezra J, Sheibani K, Kendrick FE, Winberg CD, Rappaport H. Angiotropic large cell lymphoma of the prostate gland: An immunohistochemical study. Hum. Pathol. 1986: 17; 964-967.
5. Carroll TJ Jr, Schelper RL, Goeken JA, Kemp JD. Neoplastic angioendotheliomatosis: immunopathologic and morphologic evidence for intravascular malignant lymphomatosis. Am. J. Clin. Pathol. 1996: 85; 169-175.
6. Wick MR, Mills SE, Scheithauer BW, Cooper PH, Davitz MA, Parkinson K. Reassessment of malignant angioendotheliomatosis. Evidence in favour of its reclassification as 'intravascular lymphoma'. Am. J. Surg. Pathol. 1986: 10; 112-123.
7. Sheibani K, Battifora H, Winberg CD et al. Further evidence that malignant angioendotheliomatosis is an angiotropic lymphoma. N. Eng. J. Med. 1986: 314; 943-948.
8. Molina A, Lombard C, Donlon T, Bangs CD, Dorfman RD. Immunohistochemical and cytogenetic studies indicate that malignant angioendotheliomatosis is a primary intravascular (angiotropic) lymphoma. Cancer 1990: 66; 474-479.
9. Otrakji CL, Voigt W, Amador A, Nadfi M, Gregorios JB. Malignant angioendotheliosis, a true lymphoma. A case of intravascular malignant lymphomatosis studied by southern blot hybridization analysis. Hum. Pathol. 1988: 19; 475-478.
10. Sepp N, Schuler G, Romani N et al. Intravascular lymphomatosis (angioendotheliomatosis): evidence for a T-cell origin in two cases. Hum. Pathol. 1990: 21; 1051-1058.
11. Daniel SE, Rudge P, Scaravilli F. Malignant angioendotheloisis involving the nervous system: support for a lymphoid origin of the neoplastic cells. J. Neurol. Neurosurg. Psych. 1987: 50; 1171-1177.
12. Glass J, Hochberg FH, Miller DC. Intravascular lymphomatosis. A sytemic disease with neurologic manifestations. Cancer 1993: 71; 3156-3164.
13. Demirer T, Dail DH, Aboulafia DM. Four varied cases of intravascular lymphomatosis and a literature review. Cancer 1994: 75; 1738-1745.
14. Stroup RM, Sheibani K, Moncada A, Purdy J, Battifora H. Angiotropic (intravascular) large cell lymphoma. A clinicopathologic study of seven cases with unique clinical presentations. Cancer 1990: 66; 1781-1788.
15. Wick MR, Banks PM, McDonald TJ. Angioendotheliomatosis of the nose with fatal dissemination. Cancer 1981: 45; 2510-2517.
16. Ferry JA, Harris NL, Picker LJ et al. Intravascular lymphomatosis (malignant angioendotheliomatosis): a B cell neoplasm expressing surface homing receptors. Mod. Pathol. 1988: 1; 444-452.
17. Jalkanen S, Aho R, Kallajoki M et al. Lymphocyte homing receptor and adhesion molecules in intravascular lymphomatosis. Int. J. Cancer 1989: 44; 777-782.
18. Wong MP, Chung LP, Yuen ST et al. In situ detection of Epstein-Barr virus in non-small cell lung carcinomas. J. Pathol. 1995: 177; 233-240.
19. DiGiuseppe JA, Nelson WG, Seifter EJ, Boitnott JK, Mann RB. Intravascular lymphomatosis: A clinicopathologic study of 10 cases and assessment of response to chemotherapy. J. Clin. Oncol. 1994: 12; 2573-2579.
20. Shimokawa I, Higami Y, Sakai H, Moriuchi Yk Murase K, Ikeda T. Intravascular malignant lymphomatosis: a case of T-cell lymphoma probably associated with human T-cell lymphotropic virus. Hum. Pathol. 1991: 22; 200-202.
21. Sangueza O, Hyder DM, Sangueza P. Intravascular lymphomatosis: report of an unusual case with T cell phenotype occcurring in an adolescent male. J. Cutan. Pathol. 1992: 19; 226-231.
22. Tateyama H, Eimoto T, Tada T, Kamiya M, Fujiyoshi Y, Kajiura S. Congenital angiotropic lymphoma (intravascular lymphomatosis) of the T-cell type. Cancer 1991: 67; 2131-2136.
23. Deacon EN, Pallesen G, Niedobitek G et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of viral latency in the malignant cells. J. Exp. Med. 1993: 177; 339-349.
24. Klein G. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 1994: 77; 791-793.
25. Qudejans JJ, Jiwa M, van den Brule AJC et al. Detection of heterogenous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders. Am. J. Pathol. 1995: 147; 923-933.
26. Harabuchi Y, Yamanaka N, Akikatsu K et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990: 335; 128-130.
27. Minarovits J, Hu LF, Imai S et al. Clonality, expression and methylation of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. J. Gen. Virol. 1994: 75; 77-84.
28. Chang YS, Su IJ, Chung PJ et al. Detection of an Epstein-Barr virus variant in T cell lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int. J. Cancer 1995: 62; 673-677.
29. Jaffe ES, Chan JKC, Su IJ et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: definitions, differential diagnosis, and epidemiology. Am. J. Surg. Pathol. 1996: 20; 103-111.
30. Chiang AKS, Tao Q, Srivastava G, Ho FCS. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int. J. Cancer 1996: 68; 285-290.
31. Brooks L, Yao QY, Rickinson AB, Young LS. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J. Virol. 1992: 66; 2689-2697.
32. Chiang AKS, Srivastava G, Lau PWF, Ho FCS. Differences in T cell receptor gene rearrangement and transcription in nasal lympho1 mas of natural killer and T cell types: implications on cellular origin. Hum. Pathol. 1996: 27; 701-707.
33. Chan JKC, Tsang WY, Lau WH et al. Aggressive T/natural killer cell lymphoma presenting as testicular tumor. Cancer 1996: 77; 1198-1205.
34. McClain KL, Leach CT, Jenson HB et al. Association of Epstein-Barr virus with leiomyosarcoma in children with AIDS. N. Engl. J. Med. 1995: 332; 12-18.